Aticef-T 1.125 Injection
By Aticef-T
Rx
1 Powder for Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Algen Healthcare Limited
134/2, Village Khara Kheri, Sadhaura Road, Kala Amb, Distt. Sirmour H.P 173030

Expires on or after
November, 2025

liver
For individuals with severe liver disease, it is important to exercise caution when using Aticef-T 1.125 Injection. In such cases, dose adjustment may be necessary, and it is advisable to consult your doctor before starting treatment. However, for patients with mild to moderate liver disease, dose adjustment of Aticef-T 1.125 Injection is generally not required. Remember to always follow your doctor's guidance regarding the use of this medication to ensure your safety and well-being.

kidney
Caution should be exercised when using Aticef-T 1.125 Injection in patients with kidney disease. It is advisable to consult your doctor for guidance.

alcohol
When using Aticef-T 1.125 Injection, it is safe to consume alcohol as it does not produce negative side effects.

driving
When using Aticef-T 1.125 Injection, be cautious while driving as it may reduce alertness, cause dizziness, and affect vision. Avoid driving if feeling sleepy or dizzy to ensure safety.

pregnancy
Aticef-T 1.125 Injection is generally considered safe to use during pregnancy. Animal studies indicate minimal adverse effects on the developing baby. Limited human studies are available.

breastfeeding
During breastfeeding, use Aticef-T 1.125 Injection with caution. It is advised to pause breastfeeding until the mother's treatment is completed and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹199.9
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025